Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia
NCT ID: NCT06951347
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2025-05-01
2025-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It aims to answer:
* Does sodium supplementation lower the length of hospital stay in children with pneumonia?
* Does potassium supplementation lower the length of hospital stay in children with pneumonia?
Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay.
Participants will:
• Take one sachet of oral rehydration solution (ORS) every day for 3 days.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
NCT02469597
Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis
NCT01238848
Supplemental Parenteral Nutrition in Pediatric Respiratory Failure
NCT01937884
Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
NCT00261937
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
NCT04041791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days.
All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Oral Rehydration Solution
one sachet every day for 3 days
Control Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Rehydration Solution
one sachet every day for 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.
Exclusion Criteria
* Those whose parents will show disapproval for the participation of the study.
* Children on medications that affect sodium and potassium levels.
1 Month
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Organization for Teaching Hospitals and Institutes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Taha, MD
Fellow of Pediatrics, Mataria Teaching Hospital (Principal Investigator)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marwa Taha, MD
Role: PRINCIPAL_INVESTIGATOR
Mataria Teaching Hospital, General Organization for Teaching Hospitals and Institutes, Cairo, Egypt
Hoda Atef Abdelsattar Ibrahim, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Cairo University, Cairo, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mataria Teaching Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM000174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.